These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10406691)

  • 21. Platelet glycoprotein IIb/IIIa receptor blockade after coronary angioplasty.
    Gambassi G; Landolfi R; Bernabei R
    N Engl J Med; 1997 Oct; 337(17):1243-4. PubMed ID: 9340528
    [No Abstract]   [Full Text] [Related]  

  • 22. Minimally invasive bypass surgery.
    Dragu RE
    N Engl J Med; 2002 Dec; 347(26):2165-8; author reply 2165-8. PubMed ID: 12501850
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro measurement of platelet glycoprotein IIb/IIIa receptor blockade by abciximab: interindividual variation and increased platelet secretion.
    Rossi F; Rossi E; Pareti FI; Colli S; Tremoli E; Gallo L
    Haematologica; 2001 Feb; 86(2):192-8. PubMed ID: 11224490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycoprotein IIb/IIIa inhibitors: current indications and future prospects.
    Reginelli JP; Topol EJ
    Am J Med; 2000 Aug; 109(3):252-4. PubMed ID: 10974193
    [No Abstract]   [Full Text] [Related]  

  • 25. Platelet GP IIb/IIIa inhibition in myocardial infarction treated by coronary stenting: ready for prime time.
    Anderson HV
    J Invasive Cardiol; 2000 Mar; 12(3):140-1. PubMed ID: 10877555
    [No Abstract]   [Full Text] [Related]  

  • 26. Post-procedural patient management: prevention and management of bleeding complications.
    Aguirre F
    J Invasive Cardiol; 1994; 6 Suppl A():34A-37A; discussion 54A-56A. PubMed ID: 10155093
    [No Abstract]   [Full Text] [Related]  

  • 27. Early and late clinical outcome following coronary angioplasty performed with platelet glycoprotein IIb/IIIa receptor inhibition: the EPIC Trial results.
    Popma JJ; Satler LF
    J Invasive Cardiol; 1994; 6 Suppl A():19A-28A; discussion 45A-50A. PubMed ID: 10155090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet glycoprotein IIb/IIIa inhibitors: basic and clinical aspects.
    Nurden AT; Poujol C; Durrieu-Jais C; Nurden P
    Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2835-40. PubMed ID: 10591658
    [No Abstract]   [Full Text] [Related]  

  • 29. Future trials of antiplatelet agents in cardiac ischemia.
    Throckmorton DC
    N Engl J Med; 2001 Jun; 344(25):1937-9. PubMed ID: 11419432
    [No Abstract]   [Full Text] [Related]  

  • 30. Glycoprotein IIb/IIIa receptor blockers in acute coronary syndromes.
    Melandri G
    Lancet; 2001 Dec; 358(9297):1997. PubMed ID: 11747953
    [No Abstract]   [Full Text] [Related]  

  • 31. Optimal treatment of acute coronary syndromes--an evolving strategy.
    Boden WE; McKay RG
    N Engl J Med; 2001 Jun; 344(25):1939-42. PubMed ID: 11419433
    [No Abstract]   [Full Text] [Related]  

  • 32. In vitro effects of the platelet glycoprotein IIb/IIIa receptor antagonists c7E3 Fab on the activated clotting time.
    Levy JH; Kelley A
    Circulation; 1997 Nov; 96(10):3793-4. PubMed ID: 9396497
    [No Abstract]   [Full Text] [Related]  

  • 33. The platelet, the patient, and periprocedural infarction during percutaneous transluminal coronary angioplasty.
    Fischman DL; Savage MP
    JAMA; 1997 Aug; 278(6):518-9. PubMed ID: 9256229
    [No Abstract]   [Full Text] [Related]  

  • 34. Platelet glycoprotein IIb/IIIa inhibitors.
    Hellstrom HR
    Circulation; 2003 Feb; 107(5):E39-9. PubMed ID: 12578891
    [No Abstract]   [Full Text] [Related]  

  • 35. Activating effects of GPIIb/IIIa blockers: an intrinsic consequence of ligand-mimetic properties.
    Peter K; Schwarz M; Bode C
    Circulation; 2002 May; 105(21):E180-1. PubMed ID: 12034670
    [No Abstract]   [Full Text] [Related]  

  • 36. Duration of action of GpIIb-IIIa antagonists.
    Johnson K
    Crit Care Nurse; 2000 Oct; 20(5):16. PubMed ID: 11878484
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of abciximab for aneurysm coiling.
    Kapur S; da Silva EJ
    Anaesthesia; 2006 Jul; 61(7):720-1. PubMed ID: 16792629
    [No Abstract]   [Full Text] [Related]  

  • 38. Abciximab (ReoPro) removal with a hemoconcentrator during cardiopulmonary bypass.
    Lemmer JH
    J Thorac Cardiovasc Surg; 1999 Nov; 118(5):980-1. PubMed ID: 10534719
    [No Abstract]   [Full Text] [Related]  

  • 39. Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics.
    Coller BS
    J Clin Invest; 1997 Dec; 100(11 Suppl):S57-60. PubMed ID: 9413403
    [No Abstract]   [Full Text] [Related]  

  • 40. Microcirculatory effects of abciximab and eptifibatide: a critical appraisal.
    Kereiakes DJ
    J Invasive Cardiol; 2003 Sep; 15(9):481-3. PubMed ID: 12947205
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.